Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
drug launch
Pharma
NICE advises against Merck's Lagevrio, AZ's Evusheld, 3 others
Five key products used to combat COVID-19—including Merck’s Lagevrio and AstraZeneca’s Evusheld—could be rejected for government funding in the U.K.
Kevin Dunleavy
Nov 16, 2022 10:43am
Pfizer, GSK prep for battle in the world's first RSV vax market
Nov 3, 2022 9:50am
'The Top Line': Biogen's earnings call, AstraZeneca's CTLA-4 nod
Oct 28, 2022 6:00am
Pfizer gears up for 'pivotal' 2023, CEO says
Oct 20, 2022 8:19am
Eli Lilly bests Big Pharma on value of new launches: report
Sep 26, 2022 8:24am
Novartis files FDA appeal in bid to block Entresto generics
Sep 16, 2022 11:28am
